We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Gene Discovered for Congenital Heart Disease

By LabMedica International staff writers
Posted on 13 Jun 2013
Print article
A gene has been identified with a form of congenital heart disease (CHD) which is the most frequent congenital disorder in newborns.

Most patients born with CHD now survive to adulthood, so identifying the responsible genes is important as experts attempt to provide individual-specific genetic counseling for these people.

An international team of scientists, led by those at the University of Manchester (Greater Manchester, UK) and Newcastle University (Newcastle upon Tyne, UK) conducted a genome-wide study of over 2,000 CHD patients and measured over 500,000 genetic markers, which vary in the general population. The genetic markers in the patients were compared to the markers of over 5,600 people in good health who acted as a control group.

The scientists found a relationship between a particular region of the human genome and risk of atrial septal defect (ASD), which is a form of congenital heart defect that enables blood flow between two compartments of the heart called the left and right atria. The investigators went on to confirm their findings in additional cases of atrial septal defect and healthy controls.

When all CHD phenotypes were considered together, no region achieved genome-wide significant association. However, a region on chromosome 4p16, adjacent to the muscle-segment homeobox 1 (MSX1) and syntaxin 18 (STX18) genes, was associated with the risk of ostium secundum atrial septal defect in the 340 cases in the discovery cohort, and this association was replicated in a further 417 ASD cases and 2,520 controls.

Bernard Keavney, MD, professor of cardiology and senior author of the study, said, “Identifying a gene associated with one type of CHD was an important step forward. We found that a common genetic variation near a gene called MSX1 was strongly associated with the risk of a particular type of CHD called atrial septal defect or hole in the heart. ASD is one of the most common forms of congenital heart disease, and it carries a risk of heart failure and stroke. We estimated that around 10% of ASDs may be due to the gene we found. We can now work to find out how MSX1 and/or its neighbor genes affect the risk of ASD." The study was published on May 26, 2013, in the journal Nature Genetics.

Related Links:

University of Manchester

Newcastle University



Gold Member
Rickettsia Conorii Assay
RICKETTSIA CONORII ELISA
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
Pregnancy Test
CLINITEST hCG
New
Gold Member
Serological Pipet Controller
PIPETBOY GENIUS

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The discovery of a new blood group has solved a 50- year-old mystery (Photo courtesy of 123RF)

Newly Discovered Blood Group System to Help Identify and Treat Rare Patients

The AnWj blood group antigen, a surface marker discovered in 1972, has remained a mystery regarding its genetic origin—until now. The most common cause of being AnWj-negative is linked to hematological... Read more

Microbiology

view channel
Image: The inbiome molecular culture ID technology has received FDA breakthrough device designation (Photo courtesy of inbiome)

Revolutionary Molecular Culture ID Technology to Transform Bacterial Diagnostics

Bacterial infections pose a major threat to public health, contributing to one in five deaths worldwide. Current diagnostic methods often take several days to provide results, which can delay appropriate... Read more

Pathology

view channel
Image: Confocal- & laminar flow-based detection scheme of intact virus particles, one at a time (Photo courtesy of Paz Drori)

Breakthrough Virus Detection Technology Combines Confocal Fluorescence Microscopy with Microfluidic Laminar Flow

Current virus detection often relies on polymerase chain reaction (PCR), which, while highly accurate, can be slow, labor-intensive, and requires specialized lab equipment. Antigen-based tests provide... Read more

Industry

view channel
Image: The GeneXpert system’s fast PCR Xpert tests can fight AMR and superbugs with fast and accurate PCR in one hour (Photo courtesy of Cepheid)

Cepheid Partners with Fleming Initiative to Fight Antimicrobial Resistance

Antimicrobial resistance (AMR) is responsible for over one million deaths globally each year and poses a growing challenge in treating major infectious diseases like tuberculosis, Escherichia coli (E.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.